key: cord-0979918-ieva7ald
authors: Aouiss, Hani Amir; Belhaouchet, Imene
title: What about rheumatic diseases and Covid-19?
date: 2021-02-12
journal: New Microbes New Infect
DOI: 10.1016/j.nmni.2021.100846
sha: 1340be6e731a7a86e2194f8d95d0d30bf13cfda8
doc_id: 979918
cord_uid: ieva7ald

nan

gap we are faced with on a daily basis, more than ever we need massive collaboration from all 48 medical branches (including rheumatology). Indeed, the rheumatologist as one of the front 49 liners should always consider other options whenever a patient comes with common 50 rheumatic manifestations to try to limit possible transmission of the virus. 

Novel coronavirus (2019-nCoV) situation reports

World Health Organization. WHO COVID-19 case definition

Current State of the Coronavirus (Covid-19) in Algeria

Characteristics of and important lessons from the coronavirus 63 disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the 64 Chinese center for disease control and prevention

Office national de la santé

COVID-19 68 infection and rheumatoid arthritis: Faraway, so close!

Remdesivir and chloroquine effectively inhibit the 71 recently emerged novel coronavirus (2019-nCoV) in vitro

Review on the global epidemiological situation and the 74 efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19

Microbes New Infect